Purpose: In this retrospective study we aimed to compare operation data of the patients with bladder stone and benign prostatic enlargement who underwent transurethral and percutaneous cystolithothripsy with transurethral prostate resection (TUR-P).
Materials and Methods: Between august 2012 and december 2015 the patients with benign prostatic enlargement and bladder stone with the size of minimum 2 cm were included the study. Patinets who were grouped as percutaneous and transurethral cystolithothripsy underwent endoscopic or percutaneous cystolithothripsy for the bladder stone and the operations were completed with TUR prostatectomy. The stone size, prostatic volume, operation and hospitalisation time and complications were compared retrospectively.
Results: 64 patients were included the study. 30 patients were underwent percutaneous cystolithothripsy and 34 patients were underwent transurethral cystolithothripsy. The mean stone size were 3,5 ± 0,7 cm (2.2 – 5.3) at percutaneous group and 3,4 ± 0,7 cm (2.4 – 5.2) at transurethral groups. Though the operation time of percutaneous group had a significant difference, there was no significant difference for urethral catheter removal time, hospital stay and complications.
Discussion: Treatment of BPH with bladder stone, percutaneous cystolithothripsy is safe and reduces the operation time because of removing the bladder stone by large fragments and the suprapubic tube helps bladder drainage during the prostatic resection.
Percutaneous, cystolithothripsy, bladder stone.